8(a) contract

Hedge Funds and FCPA

Should Hedge Funds be Concerned with Government Enforcement of FCPA in 2014?

Three years ago, law firms and consulting firms predicted an apocalyptic future for hedge funds and private equity firms during the investigation of Allianz SE which resulted in a DOJ declination and an SEC enforcement action against Allianz. That enforcement action was premised on  improper payments to foreign officials made by Utama, a majority owned subsidiary of Allianz in Indonesia, to obtain government insurance contracts, and the recording of those payments as legitimate transaction costs in violation of the FCPA accounting provisions, Section 13(b) of the Exchange Act.

This year, however, the government has provided some guidance and has taken some steps that strongly suggest that they are sincerely committed to tackling corruption and prosecuting potential violations of the Foreign Corrupt Practices Act (FCPA) involving hedge funds and private equity firms, especially in connection with sovereign wealth funds.

Hedge Funds

 1.      GAIM Ops Cayman

In April, government agencies warned hedge funds at GAIM Ops Cayman that enforcement of the Foreign Corrupt Practices Act (FCPA) will be a priority for 2014. To this end, Sarah Coyne, chief of the Business and Securities Fraud Section at the U.S. Attorney’s Office for the Eastern District of New York and one of the chief prosecutors responsible for the investigation and global FCPA settlement with Ralph Lauren, underscored:

Hedge funds are likely to fall into two buckets. The first would be if they are soliciting investments from a foreign official or a sovereign wealth fund or pension fund controlled by the state and we will be scrutinising any gifts, entertainment or travel afforded to those individuals to ensure they do not break the rules. The other area where hedge funds may fall foul is when they invest in a market where corruption is a way of life.

Ms. Coyne further emphasized that:

The use of a third party in a jurisdiction where corruption is widespread or the use of a consultant who has awareness about the local culture and who may be dealing with a sovereign wealth fund is an area where hedge funds are most likely to get into trouble under the FCPA.

Id.

2.      Och-Ziff Capital Management Group, LLC Hedge Fund

Ms. Coyne’s above-described statements coincided with the public disclosure made by Och-Ziff to shareholders that they are conducting an internal investigation related to allegations that the Company: (1) violated relevant anti-bribery laws by accepting an investment from the Libyan Investment Authority; (2) loaned $234 million to help finance two ventures in the Democratic Republic of Congo, in violation of the Foreign Corrupt Practices Act; and (3) failed to disclose that, beginning in 2011, Och-Ziff received subpoenas from the Securities and Exchange Commission and the United States Department of Justice in connection with these transactions.

Investigations and Litigation Involving Libyan Independent Authority (LIA)

The Department of Justice initiated a Foreign Corrupt Practices Act investigation into private-equity and hedge fund dealings with LIA, a sovereign wealth fund, including Goldman Sachs, Credit Suisse, Societe Generale SA, and JP Morgan Chase. The investigation is focused on a group of “fixers,” or placement agents, operating in the Middle East, London, and elsewhere after the collapse of the Libyan government. After revolutionaries toppled the old Gadhafi regime, economic sanctions were lifted and Western firms jumped at the opportunity to invest in Libya. The placement agents may have acted as conduits to government leaders, providing direct access to members of the Libyan government.

The Libyan Investment Authority, which is a sovereign wealth fund (SWF) with an estimated value of 50-75 billion dollars sued Goldman Sachs in London’s High Court of Justice, Chancery Division in connection with losses it incurred by investing money with Goldman. The LIA claims that Goldman and its asset managers abused their relationship of trust by advising them to make investments that were too complex to understand.

Questions

Put simply, in FCPA land, this raises several questions about the extent to which the FCPA applies to investment firms (including hedge funds) when they engage placement agents, on an independent contractor basis, to develop relationships with officers, managers, or employees of sovereign wealth funds.

First, what is a sovereign wealth fund (SWF)?

A SWF is a state-owned investment fund composed of financial assets such as stock, bonds, real estate, or other financial instruments funded by foreign exchange assets. SWF’s are essential for a country’s economic growth, however, such funds can be risky depending on how capital from those funds is invested. Generally, central banks reserves, which accumulate due to budget and trade surpluses, or revenue generated from exports such as natural resources, fund the SWF.

Two other common sovereign investment vehicles are public pension schemes, for example, Japan’s government pension fund used to finance pensions for public sector employees, and state owned enterprises, which are legal entities created by the Government to seek investments on their behalf, for example, Freddie Mac or Fannie Mae. A state owned enterprise is either wholly or partially owned by a government and is typically earmarked to participate in commercial activities. Just like SWF’s the amount of money held in these vehicles is substantial.

Second, what is the purpose of engaging a placement agent, third party consultant, client relationship manager, or “fixer” in the context of attracting foreign investment from SWF’s?  Investment firms should be capable of answering this question and should, where applicable, answer the following questions:

  • Who or what department is responsible for engaging a placement agent and/or cultivating relationships with the placement agents?
  • What is the primary purpose of engaging a placement agent?
  • Is the placement agent a registered representative governed by FINRA, or a similar, foreign regulatory body?
  • What was discussed during any preliminary conversations between the firm and placement agents?
  • After the discussion(s), what was the placement agent’s understanding of (1) what her role might be in obtaining access to investment opportunities in SWF and (2) how she might obtain access to investment opportunities in SWF?
  • Who, if anyone, is responsible for monitoring or supervising the placement agent? Is the relationship completely “hands off” once the relationship commences?
  • Who or what department is responsible for monitoring any ongoing relationships with placement agents aimed at obtaining access to managers, officers, or employees of an SWF?

Third, how are the agents compensated and how is that compensation recorded?

This issue was recently addressed in In SEC v. Tomas Alberto Clarke Bethancourt, et al, No. 13-CV-3074 (S.D.N.Y. June 13, 2013). In that case, the SEC alleged that the emerging markets arm, located in Miami, of a New York broker-dealer, was funneling bribes to officials of a state-owned bank in Venezuela in return for transaction fees – in the form of markups and markdowns – on riskless principal trade executions in Venezuelan sovereign state bonds. Part of the scheme involved the use of a “foreign finder” located in Panama to identify investment opportunities in Venezuela.

Further, in the parallel criminal case, the Department of Justice indicted several individuals (some of whom later pled guilty), including the manager of the Miami branch, for violations of the anti-bribery provisions of the FCPA.

Against this backdrop, firms might ask some of the following questions:

  • How are placement agents’ compensated, flat fee or commission?
  • Is an independent consultant retained to assess the fair market value of any fee? Do they conduct a fair market valuation to determine the reasonableness of the fee?
  • Is payment properly recorded in the firm’s books and records?
  • If so, how is any agent compensation recorded in the investment firm’s books and records? Is it recorded as a consulting fee?
  • How is payment made to the placement age, check, cash, wire transfer, etc?
  • Is payment made directly to the placement agent individually or to a company or entity designated by the placement agent to receive payment?
  • If so, how is that payment recorded in the firm’s books and records?

Finder’s Fee?

  • Is the placement agent awarded a “finder’s fee?”
  • If so, how is the finder’s fee calculated?
  • If so, does the firm confirm that the foreign finder is not required to register in the U.S. as a broker/dealer nor is subject to disqualification?
  • If so, does the firm confirm that the finder is a foreign national or entity domiciled abroad?
  • If so, does the firm confirm that the customers referred by the finder are foreign nationals or entities?
  • Does the firm disclose what compensation is to be paid to the finder to the customers/investors?
  • Does the firm provide investors/customers with a written acknowledgement of the compensation arrangement and, if so, does the firm currently maintain a copy of such acknowledgement?
  • Does the firm maintain records reflecting finder compensation?

Fourth, what is the placement agent’s role, if any, in providing the firm with access to employees, managers, or officers of the SWF? 

Additional questions the firm might ask in this context are as follows:

  • How does the firm regulate or supervise the degree of influence its placement agents may exercise in seeking to obtain pledges to invest in the fund?
  • How does the firm define “anything of value” in its Code of Conduct and/ FCPA/Anti-Corruption Compliance Policy?
  • Does the Policy narrowly circumscribe the permissible conduct of agents in this context?
  • Does the Policy narrowly circumscribe the permissible categories of “anything of value” in this context?
  • How would the firm record “anything of value,” offered to any employee, officer, or manager of an SWF in its books and records, including entertainment, travel, gifts, or equipment?

Fifth, are employee, managers, or officers, with whom the placement agents interact, officers or employees of a foreign government, or any department, agency or instrumentality thereof?

At first blush, answering this question may appear simple, but there is a significant appeal pending before the Eleventh Circuit in United States v. Esquenazi, et. al which addresses this precise issue. Indeed, during oral arguments before the Eleventh Circuit Court of Appeals, one of the main questions on appeal is whether the convictions of defendants, telecommunications executives, should be reversed based on the district court’s refusal to grant defendants’ instruction regarding the definition of “foreign official,” specifically the definition of what constitutes an “instrumentality” of a foreign government.

The appellate attorney representing the Department of Justice underscored that an instrumentality is an entity through which government exercises its function and has dominion and control.

Further, the U.S. District Court for the Central District of California in United States v. Aguilar, 783 F. Supp. 2d 1108(C.D. Cal. 2011)emphasized that there are several factors court should consider in deciding whether an entity is an instrumentality of a foreign government:

  • The entity provides a service to the citizens — indeed, in many cases to all the inhabitants — of the jurisdiction.
  • The key officers and directors of the entity are, or are appointed by, government officials.
  • The entity is financed, at least in large measure, through governmental appropriations or through revenues obtained as a result of government-mandated taxes, licenses, fees or royalties, such as entrance fees to a national park.
  • The entity is vested with and exercises exclusive or controlling power to administer its designated functions.
  • The entity is widely perceived and understood to be performing official (i.e., governmental) functions.

Thus, under current FCPA jurisprudence, an officer or employee of a SWF may very likely constitute an “instrumentality” of a foreign government. So, unless the Eleventh Circuit significantly narrows the definition of “instrumentality” in Esquenazi, that is the position that the DOJ is likely to maintain in future enforcement actions, investigations, and prosecutions related to the FCPA.

Conclusion

Given the current enforcement landscape and the government’s current investigations involving placement agents and SWF’s, hedge funds and private equity firms would be well-advised to review their internal policies and procedures addressing SWF’s and placement agents.

Keep in mind, this Note does not address the other anti-corruption laws that may apply in this context and firms seeking to attract foreign investment through the implementation of third party consultants in high risk countries should review and enhance compliance with the applicable anti-corruption laws.

Share this post
Money-2

I Received an IRS Summons

What is an IRS Summons?

Summonses may be issued either to the taxpayer, or a third party, for information necessary to the proper calculation of a taxpayer’s tax liability. Summonses can also be used to determine whether a tax return is correct, to prepare a return where none has been prepared, or to collect tax.  To obtain this information, the IRS may serve a summons directly on the subject of the investigation or any third party, for example, a bank, who may possess relevant information. In doing so, the IRS may examine books and records, including documents, financial statements, etc., and may command the person possessing the records or anyone else with information relevant to the IRS investigation, to appear before an official of the IRS.

Is an IRS Summons the First Notice I Should Have Received?

According to recent guidance from the IRS, the IRS should typically send several documents to a taxpayer prior to issuing a formal summons. Those documents might include: (1) IRS Form 4564, an Information Document Request, as an informal request to produce information and documents relevant to a determination of the taxpayer’s tax liability, prior to issuing a formal summons (2) a delinquency letter stating that the taxpayer has not yet produced the relevant documents and (3) a pre-summons letter.

If you have received any of the above-described documents or an IRS summons, it is absolutely critical that you contact an attorney. Far too frequently, taxpayers ignore the summons or they mistakenly believe they can resolve the situation themselves by producing the necessary documents and by making a convincing presentation to a seasoned IRS investigator.

What Form does the IRS Use for Summons?

The IRS uses various Forms for civil summonses, included but not limited to Forms 6637-6639 or Form 2039.  The summons may state:

You are hereby summoned and required to appear before an officer of the Internal Revenue Service, to g ive testimony and to bring with you and to produce for examination the following books, records, papers, and other data relating to the tax liability or the collection of the tax liability or for the purpose of inquiring into any offense connected with the administration or enforcement of the internal revenue laws concerning the person identified above for the periods shown.

The IRS usually personally serves a summons but agents can also leave the summons with a person of suitable age and discretion. A summons may also be served on a business entity.

What Type of Summons Have I Received?

Generally, there are two types of summons, (1) a summons directly to the taxpayer(s) or (2) a third party summons requesting information relevant to a particular taxpayer.

In many cases, the IRS is required to notify the taxpayer about other persons or entities receiving the third-party summons. Two significant exceptions to this notice rule are: (1) the summons was issued in connection with a criminal investigation to a person who is not a third-party record keeper, e.g., a bank, an accountant, an attorney, a broker, an enrolled agent, an investment company, etc., (2) the summons was issued in aid of collection of an assessment made or judgment rendered against the person with respect to whose liability the summons is issued. In other words, there has already been a judgment or an assessment made against the taxpayer and the summons is an effort to collect monies from the taxpayer.

Can I Ignore the Summons?

Federal courts may enforce summonses and a person may be held in contempt or, in some cases, may be subject to criminal prosecution for a failure to obey a summons. Therefore, you should contact an attorney as soon as possible if you receive an IRS summons.

Can I Challenge a Summons?

A taxpayer receiving a summons may wait for the IRS to petition to enforce the summons and may then challenge the petition. However, generally, the IRS’ may show that the summons is valid and enforceable by attaching a declaration or an affidavit stating that: the summons was issued for a legitimate purpose, the information sought is relevant to that purpose, the IRS has taken all of the required administrative steps, and the IRS does not possess the information requested in the summons.

A taxpayer may also challenge a third party summons, assuming the taxpayer is entitled to notice of the summons, for several reasons. Keep in mind, however, that there are strict notice and time requirements for challenging a third party summons.

May I Hire an Attorney During This Process?

If you have received summons in connection with your personal tax liability, you would be well-advised to ensure that an attorney is present during any meeting with an IRS official. An attorney may assist you in answering the IRS official’s question and will determine when, and on what basis, you might refuse to answer the official’s questions.

If you have received a summons, in connection with someone else’s tax liability, you may be entitled to have an attorney present during any meeting with an IRS official.

Should I Produce All of the Documents Mentioned in the Summons?

With the assistance of an attorney, you may evaluate which documents are relevant and, more importantly, which documents should be produced. Assessing which documents should be produced is a complicated task that you should not attempt to accomplish without the assistance of an attorney.  Hiring an attorney may also help a tax payer avoid the possibility of unknowingly or inadvertently producing documents that are potentially incriminating or contain privileged information. Further, if you decide not to produce certain documents, then the IRS may challenge your reasons for not producing those documents. For example, even if you assert the Fifth Amendment as the basis for not producing the documents, the IRS may object based on several legal doctrines. Therefore, engaging an attorney to guide you through this process is critical.

Mr. Feldman has experience in civil and criminal tax matters and the Firm is well-positioned to assist taxpayers in this process.

Share this post
GavelScale

Medical Necessity Prosecutions: An Analysis of Past, Present, and Future Prosecutions

Andrew S. Feldman[i]

The health care fraud statute is not a medical malpractice statute nor is its civil corollary, the False Claims Act (FCA). Yet, recently, the Criminal Division of the Department of Justice has bulked up on its health care fraud indictments against physicians for performing medically unnecessary surgeries or procedures. Similarly, the Civil Division has filed several qui tam actions against physicians alleging that they violated FCA by submitting claims for payment to the government for medically unnecessary surgeries or procedures. Thus far, the list of defendants includes interventional cardiologists, dermatologists, and spinal surgeons and there is no reason to believe that “medical necessity” will stop trending as a theory of prosecution in U.S. Attorney’s offices nationwide.

Nonetheless, more doctors turned defendants will and are forcing the government to prove their guilt beyond a reasonable doubt at trial in these cases. First, as a practical matter, physicians are loathe to accept the government’s interpretation of what may or may not constitute a “medically unnecessary” procedure. Indeed, some of the recently indicted physicians are highly accomplished doctors with decades of experience and specialized knowledge. Second, if a physician enters a plea of guilty then, among other things, the physician will be barred from participating in any federal or state health care programs for a period of years and the physician will be required to surrender her license to practice medicine. Third, proving fraud based on the performance of medically unnecessary procedures is difficult. In fact, in an effort to allay some of the concerns with proving intent to defraud, the government may employ confidential informants and increase their use of surreptitious recordings. Fourth, judging the reasonableness of a particular medical procedure is normally reserved for professional committees and national medical associations, not federal prosecutors and juries, but courts frequently permit expert testimony concerning the propriety of a particular procedure. Fifth, even if a doctor were convicted at trial, calculating loss in these cases may present some significant hurdles for the government and defense counsel.

This article aims to first discuss some of the successful prosecutions of physicians for performing unnecessary heart stenting procedures,[ii] and some of the ongoing prosecutions, including at least one qui tam action. The article will then address some of the challenges that are likely to arise in future medical necessity investigations and prosecutions.

  1. Cardiologists and Coronary Stents

Notably, since 2012, at least two Circuit Courts of Appeals have upheld the convictions of cardiologists for health care fraud based on their repeated performance of unnecessary coronary stenting2 procedures to treat coronary artery disease (CAD).[iii]

John McLean

In Mclean, the criminal investigation first began after a quality control review revealed that defendant cardiologist had placed a stent in a coronary artery with no significant blockage or stenosis[iv] and after the medical center for which defendant worked identified several additional instances of possible inappropriate stent procedures. Later on, the FBI obtained a search warrant after attempts to subpoena medical records from defendant proved unsuccessful and discovered subpoenaed files stacked on defendant’s desk and a shred bin nearby. Eventually, Dr. McLean demanded a trial and was convicted on all counts. At trial the quality and quantity of the government’s evidence of guilt appeared overwhelming. Expert witnesses, patients, coworkers, nurses, and other hospital staff all testified against Dr. McLean. Significantly, both experts opined that Dr. McLean had “grossly overstated” the level of blockage in numerous patient files and one expert found that, among the 59 cases he reviewed, Dr. McLean recorded blockage of 80-90% when the level of blockage was no more than 10-30%. By comparison, Dr. McLean’s expert testified that elective stents were medically necessary as long as there was at least 50% stenosis, but also disagreed with the percentage of stenosis Dr. McLean recorded in his evaluation of patient angiograms.

Making matters worse, Dr. McLean’s nurse testified that he frequently disagreed with the percentages that he recorded and added that the hospital staff sarcastically referred to healthy lesions that did not require stenting as “McLean 90 percenters” and a dissatisfied patient testified that, when she directly confronted Dr. McLean about why she had received a coronary stent, he responded “because it was easy, why not?” And, finally, peer comparison data introduced at trial demonstrated that Dr. McLean performed nearly twice as many elective stenting procedures as his peers.

On appeal, Dr. McLean raised several arguments. First, McLean argued that the health care fraud statute was unconstitutionally vague as applied to him because no government standard or professional guideline defined the stenosis level needed to justify a coronary stent and the reading of angiograms is inherently subjective. McLean, at 136. The Court rejected this argument finding that the statute prohibited McLean from willfully defrauding insurers by falsely certifying that the stents he placed in patients with little to no blockage were medically necessary, which “necessarily entails proof that he knew the stent procedures were unnecessary.” McLean, at 1363.

Second, McLean claimed that the evidence at trial was insufficient. The Court, however, concluded that the specific intent to defraud private and government payors may be inferred by the totality of the circumstances which included, among other things: a pattern of overstating blockage by a wide margin and placing unnecessary stents in a large number of patients, the stark disparity between what Dr. McLean recorded and what the angiograms revealed, McLean’s admission that he placed a stent in one patient because it was “easy,” and McLean’s undeniable financial motive. Nonetheless, in so holding, the court also highlighted an important distinction between negligence and fraud:

[W]e do not believe that the pattern evidence showing that a physician placed more unnecessary stents than the national average   necessarily would be probative of fraud, for such a pattern might only suggest negligence. The distinction here is that McLean repeatedly overstated blockage by a margin well beyond the normal variation between observers.

McLean, at 138-39.

Mehmoud Patel

Similar to the government’s prosecution of Dr. McLean, in Patel, the government introduced expert witnesses, peer review data, and other evidence probative of fraud to ultimately convince jurors that Dr. Patel, the former Chief Cardiologist at LSU Medical Center, defrauded Medicare and Medicaid when he repeatedly performed unnecessary coronary stent procedures. Dr. Patel, however, was acquitted of 41 of the 91 counts at trial and he testified on his own behalf, as an expert witness, for 19 days.

On appeal to the Fifth Circuit, Dr. Patel raised many of the same arguments as Dr. McLean did. Unlike Mclean, the Fifth Circuit in Patel at least recognized that a vagueness challenge to Section 1347 was not “insubstantial” noting that “medical necessity [of cardiac treatments] hinges on the judgment of physicians” and “judgments may be quite subjective.” Patel, at *5. Yet, the court also underscored that Dr. Patel testified that he knew that medical necessity was personally intelligible as applied to the procedures underlying his convictions. Id. at *5.

In response to Dr. Patel’s sufficiency challenge, the Court emphasized that in count after count the evidence illustrated that Dr. Patel falsified the level of blockage in patient records to justify unnecessary stenting procedures. Patient records also showed complaints relating to chest pain while those patients testified that no such complaints were ever made which was probative of fraud. Patel, at *9. And, once the investigation began, Dr. Patel “changed course” ordering fewer procedures which suggested “consciousness of guilt.” Id. at * 9.

Another critical issue raised on appeal was whether or not the district court erred in admitting the expert testimony of a cardiologist-medical ethicist regarding the standards to which the medical profession generally holds itself. Relying on cases from other circuits where the defendant physicians were convicted of pharmaceutical diversion in violation of Section 846, not health care fraud, see United States v. McIver, 470 F.3d 550, 559 (4th Cir. 2006) and United States v. Feingold, 454 F.3d 550, 559 (9th Cir. 2006), the Court found that such testimony was relevant evidence and observed that “evidence that a physician deviated drastically from accepted medical standards is probative of criminal liability.” Patel, at *24, quoting McIver, 470 F.3d at 559.

In sum, while the prosecution of any physician based on his or her medical judgment is a disturbing, amorphous concept deserving of the type of vagueness challenges raised in Patel and McLean, the government’s evidence against Patel and McLean at trial overwhelmingly demonstrated that the two physicians had done much more than simply perform unnecessary or ill-advised procedures that were inconsistent with the then existing generally accepted standards in the medical community. The evidence adduced at trial showed that they repeatedly and intentionally overstated arterial blockage percentages, falsified patient records, and performed an abnormally high volume of procedures in comparison to their peers. Further, neither trial involved what might be viewed as a “battle of the experts” normally reserved for civil trials involving medical malpractice claims. Patel never called an expert and, putting aside all of the expert testimony in McLean’s trial, McLean himself made damaging admissions that were introduced into evidence regarding his inclination to stent which was well-known amongst his nurses and other hospital staff.

  1. Ongoing Prosecutions John Mitchell and Harold Persaud

More recently, the United States indicted cardiologists John Mitchell for almost identical conduct, performing unnecessary stent procedures while falsifying the percentage of “stenosis” or blockage recorded in patient medical records. United States v. John Mitchell, 14-CR-00306-MEF-WC (M.D. Ala. May 21, 2014) (DE-1). By comparison to the Patel and McLean indictments, there are a mere two (2) health care fraud counts and the government has elected to focus more aggressively on Dr. Mitchell’s alleged false entries concerning the level percentage of stenosis for seven (7) different patients in violation of Section 1035. United States v. John Mitchell, 14-CR-00306-MEF-WC (M.D. Ala. May 21, 2014) (DE-1 at 13-14).

The U.S. Attorney’s Office for the Northern District of Ohio also recently indicted cardiologist Dr. Harold Persaud for health care fraud and violations of Section 1035. See United States v. Harold Persaud, 14-CR-00276-PAG (N.D. Ohio Aug. 20, 2014) (DE-1). The health care fraud allegations against Dr. Persaud relate to a pattern of false stenting and a wide array of other conduct, including unnecessary follow up tests and procedures (e.g. nuclear stress tests, echocardiograms, and electrocardiograms), unnecessary and invasive imaging procedures used to determine the level of blockage in the arteries (e.g. cardiac catheterization, intravascular ultra sound, and aortograms), and referrals for unnecessary coronary artery bypass surgeries. Id. at DE-1 at 8-10. Importantly, the additional Thirteen Section 1035 counts also describe how Dr. Persaud repeatedly falsified “Cardiac Catheterization” reports by lying about the percentage of blockage appearing in patient arteries and how Dr. Persaud falsely documented symptoms of chest pain in patient files. Id. at DE1 at 11-22.[v] Both men currently await trial in Alabama and Ohio respectively.

Indictment of Esteemed Dermatologist Dr. Amir Bajoghli

In addition to the uptick in health care fraud prosecutions involving cardiologists, the government has also indicted at least one dermatologist for the performance of unnecessary Mohs surgeries.[vi]United States v. Amir Bajoghli, 14-CR-00278-GBL (N.D. Va. Aug. 12, 2014) (DE-1). But, unlike the other prosecutions previously discussed, the government in Dr. Bojaghli’s did not allege any violations of 18 U.S.C. Section 1035 and instead alleged 53 separate counts of health care fraud relating to fraudulent billing for Mohs surgeries. Id. at DE1.[vii] Of importance, here, are the allegations (Counts 1-17) specifically related to Dr. Bajoghli’s intentional misdiagnoses of benign tissue as skin cancer in order to submit fraudulent claims to Medicare. Id. at DE-1 at 7-8, 10-11.

Perhaps the most telling development in the prosecution, however, was the government’s decision to send victim statement letters to Dr. Bajoghli’s patients whom the government might call as witnesses on the eve of trial. Indeed, as underscored by defense counsel in a motion in limine, the victims are the payors, Medicare and Tricare, not patients, and sending letters to putative government witnesses is tantamount to obstruction of justice and witness tampering.[viii] Equally as important, sending letters to patients starkly reveals a government position that is untenable– that patients, not federal health care programs, are the victims in health care fraud cases involving unnecessary medical procedures or surgeries.

Tracheotomies- “Biggest Money Maker”[ix]

The indictment of the CEO of Sacred Heart Hospital, Edward Novak, in Chicago and six physicians is also noteworthy for two reasons. First, the government alleged that the hospital generated substantial profits based, in part, on the performance of unnecessary patient intubation and tracheotomy procedures. United States v. Edward Novak, et al. 13-CR-00312 (N.D. Ill. March 18, 2014) (DE-231) (Superseding Indictment). Indeed, physicians unnecessarily performed a high number of intubations[x] and prolonged them by directing the heavy sedation of patients which resulted in tracheotomies being performed. A physician would heavily sedate a patient while the patient was breathing with the assistance of a ventilator in order to increase the likelihood that the patient would fail certain respiratory tests and would ultimately require a tracheotomy. Second, during the Novak investigation, the government used hospital personnel, physicians, and patient recruiters to secretly record Mr. Novak and the physician defendants.

Parallel Actions: Dr. Aria Sabit

The parallel civil and criminal actions against Dr. Aria Sabit, a spinal surgeon, a physician investor in a POD, and an avid weight lifter, also merit discussion. See United States v. Reliance Medical Systems, LLC, et al. 14-CV-06979-DDP-PJW (C.D. Cal. Sept. 8, 2014) (DE-1 at 53-54) (Complaint); United States v. Aria Sabit, 14-CR20779-PDB-RSW (E.D. Mich. December 9, 2014) (DE-19) (Indictment).

One thing which is unusual about the Dr. Sabit indictment is that the government first intervened in a qui tam action against Dr. Sabit (the lone defendant in the complaint) and several corporate entities, including Reliance Medical Systems and Apex Technologies, before indicting Dr. Sabit three months later in the Eastern District of Michigan.

Moreover, the complaint alleges a multi-year scheme to violate the Anti-Kickback Statute in order to reap as many profits as possible from the use of spinal implants on Medicare patients. See United States v. Reliance Medical Systems, LLC, et al. 14-CV-06979-DDP-PJW (C.D. Cal. Sept. 8, 2014) (DE-1) (Complaint). According to the Complaint, Dr. Sabit entered into a long standing joint venture agreement whereby Dr. Sabit was an investor in a medical technology company (Apex) distributing spinal implants.[xi] According to the government, under this arrangement, Apex targeted physicians, (e.g. Dr. Sabit) capable of performing a high volume of spinals surgeries involving their implants. Physicians were then compensated in part based on the profits they generated for Apex by performing spinal surgeries on Medicare patients. Thus, an integral part of the government’s theory of falsity is that payments to Dr. Sabit would cause him to perform spinal surgeries using implants that were not medically necessary. See United States v. Reliance Medical Systems, LLC, et al. 14-CV06979-DDP-PJW (C.D. Cal. Sept. 8, 2014) (DE-1 at 53-54) (Complaint).

The indictment returned in the Eastern District of Michigan against Dr. Sabit was more straightforward. Dr. Sabit was accused of violating the health care fraud statute on more than a dozen occasions when he performed unnecessary spinal surgeries and subsequently falsified the CPT codes corresponding to those surgeries. United States v. Aria Sabit, 14-CR20779-PDB-RSW (E.D. Mich. December 9, 2014) (DE-19 at 8-9) (Indictment). According to the indictment, on at least four occasions, Dr. Sabit performed spinal surgeries without implanting a spinal device into the patient and then authored reports containing false statements concerning the procedure performed, the device used, and the patients’ diagnoses which resulted in the submission of incorrect CPT codes to Medicaid for services that were medically unnecessary or never rendered. Id. at 9. Based on the aforementioned prosecutions of individual physicians for the performance of unnecessary surgeries or procedures, below are some of the critical issues that defense attorneys might anticipate in future prosecutions.

More Trials

As clients, physicians can be a hand full. And, a physician client accused of criminal charges based on a lapse in judgmen1t is much more likely to assert his constitutional right to a jury trial than a physician accused of phantom billing or pocketing kickbacks. In the physician’s view, a prosecution for performing the wrong procedure amounts to egregious government over-reaching. After all, isn’t a board certified physician is in a much better position than a federal prosecutor to evaluate when or how a particular procedure should or should not be performed? Furthermore, after a physician considers the likely consequences of a plea of guilty in this context, including mandatory exclusion, loss of licensure to practice medicine, medical malpractice law suits, and a jail sentence, attorneys should expect that the client will insist on a trial, and may also insist on testifying as a defense expert.

Effect of New Qui Tam Procedure

Assistant Attorney General Leslie Caldwell announced that, as a matter of policy, DOJ will begin aggressively investigating the allegations contained in all qui tam complaints to first determine whether the allegations form the basis for criminal health care fraud prosecutions.[xii]Mr. Caldwell recognized that such a policy might delay the prosecution of viable qui tam actions, but assured relators’ counsel that such steps were necessary to address the government’s current enforcement initiatives. In practice, this means that each and every qui tam alleging medical necessity as a theory of civil liability under the False Claims Act will be screened by the Criminal Division.[xiii] Undeniably, such an initiative presents new challenges one of which is deciding what guidelines, if any, the government should formulate to determine when a physician’s conduct in knowingly performing an unnecessary procedure crosses the grey line between civil and criminal. If Mclean and Patel are the starting points for this analysis, it might be when the physician persists in fraudulent conduct attendant to the medically unnecessary procedure.

Conversely, the policy may also complicate matters for defense counsel in parallel proceedings, for example, responding to a Civil Investigative Demand (CID). Under these circumstances, where there is any reason to believe that there is a parallel criminal investigation with respect to the physician’s conduct the new procedure might cause physicians to demand an informal meeting as a substitute to sworn testimony and may also compel more physicians to invoke their Fifth Amendment rights, after assessing the risks (e.g. an adverse inference instruction) and benefits associated with taking Five. And, similar obstacles may arise in other proceedings, including a state administrative proceeding concerning the physician’s license, a medical malpractice lawsuit during which depositions are requested, or a quality control review initiated at the behest of a QIO.

Defenses at Trial: Specific Intent to Defraud, “Materiality,” and the Good Faith Defense

In a medical necessity case, unlike a run of the mill health care fraud case involving false billing, upcoding, or kickbacks, proving the necessary elements of the health care fraud statute beyond a reasonable doubt may be a more difficult challenge when compared to. Importantly, the government must prove that, a physician intended to defraud a government health care program or a private insurance company, and did so by making “materially” false or fraudulent representations, pretenses, or promises, in connection with the delivery or payment of health care benefits, items, or services.[xiv] A statement, representation, or promise cannot be material unless it is capable of influencing a person’s decision.[xv]

And, despite Congress’ addition of subsection (b) to the healthcare fraud statute, 18 U.S.C. §1347, in an effort to relax the mensrea threshold for prosecutors, stating “[w]ith respect to violations of this section, a person need not have actual knowledge of this section or specific intent to commit a violation of this section,” physicians accused with health care fraud should be entitled to freely assert a good faith defense.[xvi] In so doing, a defendant might assert that, because he held an honest good faith belief, even if mistaken, that the procedures or surgeries that were performed were necessary.[xvii] Accordingly, a physician may also be entitled to assert that she honestly believed that the statements contained in the patient records (or other medical documentation) to support those surgeries were true and accurate.[xviii] If utilized properly, this defense has the potential to eviscerate a medical necessity prosecution at trial.

Surreptitious Recordings

When compared to ambiguous email threads, or difficult to digest financial and medical records, recordings may supply jurors with powerful evidence of the defendant’s guilt. In practice, because transcripts of each and every conversation that might be introduced at trial are provided during discovery, counsel should be prepared to attack the admissibility of these recordings and to effectively cross-examine the supervising agents responsible for obtaining and preserving the recordings.

This is significant in the context of a medical necessity prosecution where the majority of the evidence against the defendant boils down to recorded statements. For example, in the Sacred Heart Hospital investigation and prosecution administrative personnel and others recorded dozens of conversations between or amongst the defendants charged in the superseding indictment. Such evidence may be introduced into evidence as part of the government’s case in chief since surreptitious recordings and confidential informants have the potential to cure some of the identifiable evidentiary deficiencies in these cases and, as such, the benefits of using these investigative techniques is undeniable. On the other hand, counsel will likely have the opportunity to cross-examine some of the other parties to the recorded exchanges, including any of the unindicted co-conspirators, or, if the government refuses to call them as witnesses, counsel might impeach those persons during the cross-examination of the agent by eliciting testimony about their deceitful conduct

For these reasons, recordings will likely continue to be a valuable asset to medical necessity prosecutions and, if the Sacred Heart case is any indicator of the future, medical necessity trials might begin looking more like drug conspiracy cases (in which recordings are frequently a centerpiece of the government’s prosecution and evidence of an unlawful agreement) than health care fraud trials.

Experts

During any medical necessity prosecution, the government must do much more than introduce experts to testify that, based on their experience, the subject procedure or surgery was medically unnecessary. If all the experts do is sensationalize the impropriety of a particular medical procedure, then the bright line between criminal and civil was never transgressed and the government has proved negligence, not fraud.[xix] This raises some interesting questions concerning experts. One significant issue is whether the courts will rigorously apply Daubert to government experts. For example, under Daubert, what methodologies employed by an expert in reaching her conclusions should be considered unreliable or the product of unreliable principles[xx] so as to warrant exclusion? Should an expert be permitted to testify that, based on his or her experience and the application of certain reliable principles, the physician performed an unnecessary surgery, or worse, in doing so, substantially deviated from the acceptable standard of care?[xxi]

Another issue with respect to experts is whether, and to what extent, a government expert (or defense expert) may testify regarding the “ultimate issue” without directly contravening Federal Rule of Evidence 704(b).[xxii]The Tenth Circuit, for example, in United States v. Schneider, 704 F.3d 1287, 1294 (10th Cir. 2013) set up a nice roadmap for how government experts can circumvent 704(b) issues on appeal. In Schneider, the expert testified that the documents evidence “an intention to deceive and defraud the system,” and that “this is a dishonest practice.” Schneider, 704 F.3d at 1294. In response to defendant’s 704(b) challenge on appeal, the Tenth Circuit found that “the rules do not prevent an expert from drawing conclusions about intent, so long as the expert does not profess to know a defendant’s intent.” Schneider, at 1294. That is also precisely what the expert in Schneider did during the following exchange:

Q: Are you telling the jury what you know to be the Defendant’s intent or are you stating what the evidence indicates to you?

A: I’m stating what the evidence indicates to me . . . .

Id. at 1294.

Lastly, what happens when the physician desperately wants his expert to testify at trial, and the court excludes the defense expert? United States v. Reddy, No.11-16146 (11th Cir. Aug. 16, 2013) may provide some answers to this question. In Reddy, defendant, a board certified radiologist, was accused of submitting and fraudulently signing thousands of tele-radiology reports without viewing patient images, but was never permitted to introduce his defense expert because the district court, among other things, was concerned with the reliability of the methods used by the expert under Daubert. Id. The expert’s proffered testimony concerned his peer review, through statistical sampling of defendant images, and his finding that based on his review of defendant’s images, his evaluations were “spot on.”

On appeal, the Eleventh Circuit found that the exclusion of the defense expert was an abuse of discretion but also found that such an abuse amounted to harmless error warranting a reversal of defendant’s health care fraud conviction. Id. [xxiii]

Availability of Charge Bargaining  

A physician accused of committing health care fraud may also be capable of convincing the government to agree to a reduced charge through “charge bargaining” depending on the egregiousness of the conduct. Some of the available reduced charges might include: 18 U.S.C. Section 1035, 18 U.S.C. Section 371, or 42 U.S.C. 1320a-7b(a). Indeed, several of the physicians discussed above, with the exceptions of Dr. Bajoghli and Dr. Sabit, were charged with 18 U.S.C. Section 1035. Each of these statutes, unlike the health care fraud statute, carry a maximum jail sentence of five years. Nonetheless, as a condition precedent to agreeing to the reduced charge, the government may require that the physician “proffer” all of the relevant facts and admit that the physician performed an unnecessary procedure in order to reap pecuniary benefits from private insurance companies and Medicare. Not surprisingly, a plea to a reduced charge might also trigger mandatory exclusion and lead to the revocation or suspension of the physician’s license to practice medicine.

Calculation of Loss at Sentencing

Convincing a judge or an AUSA to agree to a more lenient loss figure in a health care fraud case can be the difference between probation and five to ten years. Yet, in the context of a medical necessity prosecution, it might be more difficult for the government to gin up the loss figures at sentencing especially when the allegations in the indictment are limited to the physician’s performance of a few unnecessary surgeries.

But, what about statistical sampling?[xxiv] Can the government argue that, even though there were only 4 counts of health care fraud in the indictment concerning medically unnecessary surgeries, based on their expert’s review, there were 100 unnecessary surgeries?[xxv] If so, will the district court factor those surgeries into the computation of loss as relevant conduct?[xxvi] Additional questions might include: Should district courts credit the fair market value of a procedure, where services were actually rendered or provided, against the government’s loss figure?[xxvii] Do medical procedures even have an identifiable “fair market value” if the government is unwilling to pay for those procedures? Should the government agree to a loss figure that excludes certain procedures or surgeries from the calculation of loss?

Undoubtedly, in medical necessity health care fraud prosecutions, these issues, and others, will be the subject of future litigation at sentencing.

Final Thoughts

As the government increases the quantity and scope of medical necessity prosecutions, practitioners should anticipate that more physician defendants will want jurors, not judges, to decide their fate. After all, the notion of convicting a physician for conduct amounting to medical malpractice, or gross negligence might not sit well with jurors unless, as illustrated in Mclean and Patel, the government introduces clear-cut evidence of fraud and a pattern of deviating from the norms established and accepted by the medical community in order to reap significant profits from federal health care programs. Furthermore, based on the government’s new procedure concerning the investigation of qui tam actions, it is reasonable to expect that there will be enhanced coordination between the Criminal Division and Civil Division. And, it is also very likely that the government will test limits of Daubert in medical necessity trials and will continue to leverage the benefits of sophisticated investigative techniques, including surreptitious recordings, when evidence of intent is merely circumstancial. Finally, the uncertainties surrounding the proper estimation of “loss” in medical necessity cases might create opportunities for both physicians and the government to advance innovative arguments during pretrial negotiations and post-trial sentencing proceedings.

[i] Andrew S. Feldman is the managing member of Feldman Firm, PLLC in Miami, Florida. Mr. Feldman represents physicians, individuals, sales and marketing representatives in investigations and prosecutions of health care fraud and violations of the Anti-Kickback Statute. Mr. Feldman also focuses his practice on representing individuals in False Claims Act litigation.

[ii] A cardiac stent is a device placed in a coronary artery to treat CAD as part of a procedure called percutaneous coronary intervention (PCI). Generally, cardiac stents are used depending on certain characteristics of the artery including the size of the artery and the location of the blockage. When blockage is severe enough, cardiologists may also perform another procedure known as coronary bypass procedure.

[iii] Coronary artery disease (CAD) is the narrowing or blockage or the coronary arteries usually caused by the build-up of cholesterol and fatty deposits on the inner walls of the arteries which can restrict blood flow to the heart muscle by clogging the artery or by causing abnormal artery tone and function. According to the American College of Cardiology Foundation, significant CAD occurs when there is stenosis (blockage) equal to or greater than 70 percent of at least one major epicardial artery or when there is stenosis (blockage) equal to or greater than 50 percent of the left main coronary artery.

[iv] According to generally accepted standards in the medical community, a coronary stent is not medically necessary absent a diagnosis of at least 70% stenosis and symptoms of blockage such as chest pain or a positive stress test. See http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665 982/

[v] King Daughters Medical Center entered into a 41 Million dollar settlement with the Department of Justice based on allegations that it submitted false claims to Medicare and Medicaid for medically unnecessary coronary stents. See http://www.justice.gov/opa/pr/king-s-daughtersmedical-center-pay-nearly-41-million-resolveallegations-false-billing

[vi] In Mohs surgery, the dermatologist performs the dual role of skin cancer surgeon and pathologist. The procedure involves surgical removal of the visible portion of the skin cancer, along with a layer of the surrounding skin. The tissue is then divided into sections and color-coded by the Mohs surgeon while corresponding reference marks are made on the patient to indicate the source from which each section was taken. The surgeon then draws a map on the surgical site and the tissue is processed to create microscope slides for examination and analysis by the physician. The physician then examines the undersides and edges of each section for evidence of remaining cancer cells. If cancer is still present, the involved areas are carefully marked on the map and the patient is prepared to undergo removal of another layer of tissue.

See www.mohssurgery.org/i4a/pages/index.cfm?pageid= 3293

[vii] The government also alleged that Dr. Bajoghli committed health care fraud when he entered into a side agreement wherein he paid an out of state dermapathologist a per slide fee to analyze slides of patient skin tissue and then billed for that work under his National Provider ID and when Dr. Bajoghli delegated wound closure and suturing responsibilities to “unlicensed” and “unqualified” medical assistants when such procedures were not performed under his “immediate personal supervision.” In a motion to dismiss filed by counsel for Dr. Bajoghli, defense counsel highlighted the fundamental flaws in the prosecution’s fraud theory as it relates to lack of supervision and the agreement with the dermapathologist. United States v. Amir Bajoghli, 14CR-00278-GBL (N.D. Va. Aug. 12, 2014) (DE-29 at 8-20 (Memorandum in Support of Defendant’s Motion to Dismiss Counts 18 Through 60 of the Indictment)

[viii] United States v. Amir Bajoghli, 14-CR-00278-GBL (N.D. Va. October 13, 2014) (DE-43) (Motion in Limine Seeking Corrective Instructions for Certain Patient Witness).

[ix] Mr. Novak was consensually recorded when he proclaimed that tracheotomies were the hospital’s “biggest money maker.

[x] Tracheal intubation is a procedure in which a tube is placed into the windpipe through the patient’s moutor nose often to facilitate ventilation and to prevent asphyxiation or airway obstruction. See www.nlm.nih.gov/medlineplus/ency. By comparison, a tracheotomy is a surgical procedure whereby a hole is created in the front of the patient’s neck and into their windpipe to allow the patient to breathe through a newly created airway passage. Tracheotomies are generally performed when a patient’s breathing is somehow obstructed or when the patient suffers from medical conditions that require the use of a breathing machine for more than two weeks. See www.mayoclinic.com/health/trachostomoy

[xi] Dr. Sabit was also an owner of what is commonly referred to as a physician owned distributorship or POD

[xii] See http://www.justice.gov/criminal/pr/speeches/201 4/crm-speech-140917.html (“We in the Criminal Division have recently implemented a procedure so that all new qui tam complaints are shared by the Civil Division with the Criminal Division as soon as the cases are filed. Experienced prosecutors in the Fraud Section are immediately reviewing the qui tam cases when we receive them to determine whether to open a parallel criminal investigation.”)

[xiii] Based on some of the past and present prosecutions, there are several other triggering events that might lead to an investigation, including: (i) the filing of a patient complaint; an unfavorable quality control review conducted internally; (iii) an unfavorable internal billing audit; (iv) a quality control review initiated by a Medicare Quality Improvement Organization (QIO); (v) an administrative licensure proceeding; or (vi) a jealous doctor or competitor.

[xiv] United States v. Abdallah, 629 F.Supp.2d 699, 720 (S.D.Tx. 2009); United States v. Choiniere, 517 F.3d 967 (7th Cir. 2008), cert. denied, 130 S.Ct. 193 (2009).

[xv] United States v. Cunningham, 554 F. App’x 126, 127 (4th Cir. 2014); United States v. Perry, No. 1:12-CR-173 (D. Md. 2012) (Dkt. No. 63).

[xvi] United States v. Poulin, No. 2:09-CR-049 (E.D. Va. 2009) (Dkt. No. 134), conviction aff’d, 461 F. App’x 272 (4th Cir. 2012) (not for publication); United States v. Perry, No. 1:12-CR-173 (D. Md. 2012) (Dkt. No. 63), conviction aff’d, 757 F.3d 166 (4th Cir. 2014).)

[xvii] Ibid. at note 15.

[xviii] Ibid.

[xix] Mclean, at 138-39.

[xx] The multi-part test is found in Federal Rule of Evidence 702.

[xxi] This is absolutely fair game in Section 846 cases because the government must prove that the licensed medical provider’s actions were not for legitimate medical purposes in the usual course of his professional medical practice or were beyond the bounds of medical practice. See United States v. Boccone, No. 12-4949 (4th Cir. Feb. 20, 2014) (permitting expert testimony from government’s pain management expert); United States v. McIver, 470 F.3d 550, 559 (4th Cir. 2006) (same); United States v. Feingold, 454 F.3d 1001, 1007 (9th Cir. 2006) (permitting government expert to testify about the standard of care with which medical professionals generally must comply, and that Dr. Feingold’s conduct fell far short of applicable professional standard); United States v. Schneider, No. 10-3281 (10th Cir. Jan. 16, 2013) (permitting experts to testify that defendant physician engaged in conduct outside the ordinary course of medical practice). Further, as discussed at supra in Patel, a health care fraud case where the government must prove an intent to defraud, the court permitted the expert to opine that Dr. Patel drastically deviated from the standard medical procedures in performing cardiac stents and further noted that such deviation should be “probative of criminal liability.” Patel, at *24, quoting McIver, 470 F.3d at 559.

[xxii] Federal Rule of Evidence 704(b) states than an “expert witness [in a criminal case] must not state an opinion about whether the defendant did or did not have a mental state or condition that constitutes an element of the crime charged or of a defense” but an opinion offered by an expert is not objectionable just because it “embraces an ultimate issues.” See Federal Rule of Evidence 704(a).

[xxiii] See also United States ex rel. et. al. v. Aseracare Inc., No. 2:12-CV-245-KOB (N.D. Ala. Dec. 4, 2014) (granting defendants’ motion to exclude the government’s marketing expert whose proffered testimony included explaining how defendant’s marketing practices show defendants’ knowledge of its false claims reasoning that such testimony does not satisfy Daubert reliability standards and it would not be helpful to the jury). Note also that another issue which is not the subject of this article is whether or not counsel should retain an expert for the purpose of a pre-indictment discussion with the government. At this juncture, an expert might convince the government that the physician’s methods of diagnosing a disease, or certifying the necessity of a procedure, are acceptable within the medical community and, in doing so, might convince the government to decline prosecution. Or, that meeting might be problematic, lead to a quick indictment, and force the client to perhaps hire another expert.

[xxiv] See, e.g., United States v. Conner, 262 Fed. App’x 515, 2008 WL 215399 (4th Cir. Jan. 25, 2008) (on appeal of health care fraud sentence, holding that extrapolation was “an acceptable method to use in making a reasonable estimate of the amount of loss under the sentencing guidelines.”); United States v. Freitag, 230 F.3d 1019, 1025 (7th Cir. 2000) (in reviewing criminal health care fraud sentence, use of sampling to determine loss amount appropriate); United States v. Jones, 641 F.3d 706 (6th Cir. 2011) (upholding the use of extrapolation to calculate loss and restitution in a health care fraud case).

[xxv] If an expert witness were permitted to testify about those surgeries at trial pursuant to Federal Rule of Evidence 702 and the testimony was deemed either as intrinsic evidence or extrinsic evidence pursuant to Federal Rule of Evidence 404(b), then the court may consider such evidence at sentencing in its estimation of loss. See U.S.S.G., Section 2B1.1, Comment 3(C) (“the estimate of loss shall be based on available information,..”).

[xxvi] See U.S.S.G., Section 1B1.3

[xxvii] See U.S.S.G., Section 2B1.1, Comment 3(E)(i) (“Loss shall be reduced by the following…..the fair market value of the property returned and the services rendered, by the defendant or other persons acting jointly with defendant to the victim before the offense was detected..”). In United States v. Bane, 720 F.3d 818 (11th Cir. 2013), defendant owner of several durable medical equipment companies providing portable oxygen to Medicare patients, raised a somewhat different, but unsuccessful, argument to challenge his $20 million loss figure at sentencing. He argued that any oxygen that was provided to patients and was medically necessary should be credited against loss. In a noteworthy dissent, Honorable Judge Adalbeto Jordan noted that because the district court found that 90% of the oxygen provided to patients was “medically necessary” its fair market value should be credited against the total loss figure. In doing so, Judge Jordan also concluded that the “Special Rule,” found in 2B1.1 Comment 3(F)(v), which prohibits crediting for losses where “(i) services were fraudulently rendered to the victim by persons falsely posing as licensed professionals; (ii) goods were falsely represented as approved by a governmental regulatory agency; or (iii) goods for which regulatory approval by a government agency was required but not obtained, or was obtained by fraud…” should not apply to medically necessary portable oxygen. Bane, 720 F.3d at 832-33.

Share this post
Money-5

How Can I Track an IRS Criminal Investigation?

This outline will briefly track an IRS criminal investigation and the different stages of the IRS criminal investigation.

  • PART I of IRS Criminal Investigation: Revenue Agent Referral to Criminal Investigative Division. A potential criminal referral generally begins when a Revenue Agent refers the case to Criminal Investigation (CI) for review.
  • Basis for Referral. When affirmative acts or firm indications of fraud and/or willfulness exist and criminal criteria are met, a referral will be made through the Fraud Technical Advisor (FTA) to Criminal Investigation (CI) via Form 2797, Referral Report of Potential Criminal Fraud Cases.
  • Preparation of Form 2797. This is the Form that sets in motion the entire criminal referral process.
    • A Fraud Technical Advisor (FTA), a Special Agent from the Criminal Investigation (CI) division and a compliance employee or revenue agent – who is typically the source of the referral – participate in this referral process.
    • The referral will be a detailed presentation of the facts that establish firm indications of fraud and/or willfulness, including, but not limited to a description of the firm indications of fraud and/or willfulness, a taxpayer’s explanation of the firm indications of fraud and/or willfulness, the estimated criminal tax liability, and the method of proof used for income verification. If the fraudulent scheme involves multiple parties (e.g., husband and wife, corporation and corporate officers, etc.), those items will be reflected in the Form.
  • Initial Conferences and Meetings.
    • 10 days after the referral (more or less), the Special Agent will identify the subject as the primary investigation (PI) and will set up an initial conference between the referring compliance employee, the FTA and the evaluating special agent (SA).
    • The conference provides the referring IRS employee with an opportunity to explain the case in detail and address any questions regarding the potential criminal violations.
    • At this conference, they will review tax returns, evidence gathered to support the alleged offense, criminal tax computations, etc. Also, the following issues should be discussed at the initial conference:
      • Verification of income
      • Explanations offered by the taxpayer, the taxpayer’s representative, and/or the return preparer concerning the alleged offense
      • Whether returns were solicited and attempts were made to resolve the civil issues, and prior IRS action(s) involving a similar alleged offense and
      • Observations about the age, health (physical and mental), education and occupation of the taxpayer
  • Disposition Conference.
    • Another meeting, a disposition conference, will generally follow the initial conference and the same parties will attend the conference.
    • The purpose of the conference is to discuss the CI’s decision to accept or decline the referral. CI is required to provide written feedback to the referring employee regarding their decision. See IRM 25.1.3.4(1) and IRM 25.1.3.5(1)). A lawyer from IRS Office of Chief Counsel may also attend this disposition conference.
    • During this time, the FTA’s role is limited to monitoring the conference dates and response obligations to ensure all actions occur in a timely manner.
    • A decision to extend the time period within which to make a decision regarding the referral may be extended if approved by written agreement of the field territory manager ™ or other individual responsible for making that decision.
  • PART II of IRS Criminal Investigation: Taxpayer Conferences to Avoid Prosecution
  • Special Agent or Chief Criminal Investigation Division Conference
    • Process: This conference is obtained at the request of the taxpayer.
    • Attendees: taxpayer, taxpayer representative, and IRS representative from CI.
    • Objective: At the conference the IRS representative will inform the taxpayer by a general oral statement of the alleged fraudulent features of the case, to the extent consistent with protecting the Government’s interests, and, at the same time, give taxpayer sufficient facts and figures to acquaint him with the basis, nature, and other essential elements of the proposed criminal charges against him. This might include the method of proof.
    • Legal Authority: 26 C.F.R. §601.107 (“ A taxpayer who may be the subject of a criminal recommendation will be afforded a district CI conference when he requests one or where the Chief of CI determines that the conference will be in the best interests of the Government.
  • CID and IRS Office of Chief Counsel Conference
    • Process: This conference is triggered once CI forward the case to the IRS Criminal Tax attorney for consideration. IRS counsel or Special Agent from CI will then send a letter to taxpayer or taxpayer may request conference.
    • Attendees: Taxpayer, taxpayer representative, CI, and IRS Office of Chief Counsel. Taxpayer may in some cases bring a witness.
    • The conference is voluntary and therefore no Fifth Amendment rights and statements made by taxpayer (and attorney) can be used against taxpayer in subsequent proceedings.
    • Conducting the Conference
      • SAC will tell the taxpayer that the investigation has been completed with a recommendation for prosecution; the specific charges; the method of proof used for the specific charges; amount of civil tax liability;
      • Discussion of Case: CI has the discretion to discuss the case and facts or elements of the case to make the conference “as meaningful as possible.” See IRM 38.2.1.4.14
      • Taxpayer can assist on recording the conference
      • No interrogation/questioning
    • Following the Conference
      • Conference Memorandum:
        • Basic information about conference
        • Warnings to taxpayer
        • Statements of law or fact made by participants (and by whom)
        • Comments about demeanor of taxpayer or witness
      • Criminal Evaluation Memorandum (prepared by counsel): work product of IRS Office of Chief counsel about merits of the case.
        • Information about criminal subjects
        • Recommendation as to charges, counts, venue, statute of limitations
        • Memorandum should include whether attorney disagrees with CI recommendation and/or whether prosecution is warranted.
        • Executive summary of relevant conduct, amount of tax dollars, harm to government, technical tax issues, investigative techniques and any statutes of limitations issues.
        • Discussion of the evidence that establishes the elements of the criminal offenses
        • Discussion of the law
        • Tax loss computations, method of proof, and technical tax issues
        • Lifestyle of taxpayer
        • Defenses of taxpayer ***
        • Sentencing and any mitigating or aggravating factors
        • Distribution of a memorandum and SA Report to Associate Chief Counsel & Area Counsel & SAC (Special Agent in Charge) but not to DOJ.
  • Notice of Referral: Taxpayer will learn if there is a referral to DOJ or not. BUT taxpayer will not be advised if Office of Chief Counsel has sent it back to CI for additional review.
  • Legal Authority:
    • IRM 38.2.1.4.1-38.2.1.4.20 (2004)
    • 26 CFR §601.501(c): The Internal Revenue Service encourages the discussion of any Federal tax matteraffecting a taxpayer. Conferences may be offered only to taxpayers and/or their recognized representative(s) acting under a valid power of attorney. As a general rule, such conferences will not be held without previous arrangement.
  • Conferences Not Available
    • Grand Jury investigation has begun (MOST COMMON)
      • CID requests grand jury
      • No More summonses to taxpayer
      • Special Agent prepares a report deciding if evidence sufficient for an indictment
      • Conference with DOJ available to taxpayer (See below).
    • 26 U.S.C. §7215– obstruction of tax proceeding/investigation are referred directly from CI to DOJ
    • Imminent Statute of Limitations cases: cases where SOL may expire in 8-12 months may be referred directly to DOJ by CI.
    • Special processing cases
      • Politicians, tax shelter cases with conspiracy charges, publicly traded companies, 501(c) organizations, companies with $10B in gross annual revenue
    • DOJ Conference:
      • Process: request a conference before CI refers to DOJ for review.
        • If time and circumstances permit, the Tax Division generally grants a taxpayer’s written request for a conference with the Division in Washington, D.C.
        • If the taxpayer makes the request for a conference after the Tax Division has forwarded the matter to the United States Attorney, the Tax Division will deny the request and suggest that the taxpayer ask the United States Attorney for a conference.
        • The United States Attorney has discretion to grant or deny a taxpayer’s request for a conference. On rare occasions, the Tax Division may ask a United States Attorney to hold a conference and submit a written recommendation about whether the Division should change its decision regarding prosecution.
      • Legal Authority: no requirement to agree to a conference with taxpayer. See DOJ Tax Manual, Section 6-4.214 Conferences.
      • Purpose: Objective is to present evidence to DOJ showing that the case has problems – technical (e.g. SOL bar), evidentiary, etc. It is also an opportunity to raise affirmative defenses (e.g. good faith).
        • Tax Division usually advises conferees of the proposed charges, the method of proof, and the income and tax computations that the IRS recommended. The Division also advises them that these may change.
        • Taxpayer may present explanations or evidence for the Tax Division to consider in reaching a decision regarding prosecution.
      • Available in Grand Jury Investigations too.
      • No Vicarious Admissions: Unlike IRS, DOJ has stated they will not rely on this evidentiary rule that allows DOJ to introduce statements made by agent of taxpayer (lawyer) as evidence at a future proceeding (e.g. a trial).

If a taxpayer has reason to believe that there is an IRS criminal tax investigation, he or she should contact an experienced IRS criminal investigation attorney.

Share this post